Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: Core Research Group Brisbane
Location: 1/18 Kilroe St, Milton QLD
Lead Investigator: Prof David Colquhoun
Ethics Committee: This study has been reviewed and approved by South Western Sydney Local Health District Human Research Ethics Committee

Background

Dementia affects approximately 350,000 people in Australia, and is more common among the older population.  Two common types of dementia are Alzheimer’s disease and vascular dementia, which often co-exist in the same patient.

Currently there is no treatment for dementia. This study is investigating the effect of a Chinese herbal medicine formula in people with vascular dementia or Alzheimer’s disease with cerebrovascular disease over a 12 month period.

Men and women aged 40+ who have vascular dementia or mixed dementia are invited to participate. Participants with Alzheimer’s disease are also required to have had a stroke or mini-stroke in the past and/or suffer from heart disease. Participants are required to attend 8 study visits at one of the recruitment sites and will be reimbursed for travel costs (up to $240) for completing this study.

Benefits of Participation

• You may experience an improvement in your dementia symptoms.
• You will be compensated up to $240 for completing this study.
• You will be helping to advance medical research.

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

• Men and women aged 40+ years old who:
• Have Vascular Dementia
• OR
• Have Alzheimer’s disease AND have one of the following: a stroke or mini-stroke in the past OR history of heart disease (such as high cholesterol, stent implant, high blood pressure).
• Able to take two small capsules twice a day for 12 months.
• Able to attend 8  study visits at the recruitment site over approximately 15 months (12 months intervention plus a 3 month follow-up).